|
Volumn 180, Issue 1, 2002, Pages 13-21
|
Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: Effect of celecoxib and rofecoxib
|
Author keywords
Caspase 3; Celecoxib; Cyclooxygenases; Primitive neuroectodermal tumors; Rofecoxib
|
Indexed keywords
CASPASE 3;
CELECOXIB;
CYCLOOXYGENASE 2;
PROTEIN BCL 2;
PROTEIN KINASE B;
ROFECOXIB;
SOMATOMEDIN C;
ARTICLE;
BRAIN TISSUE;
CELL GROWTH;
CELL PROLIFERATION;
CELL SURVIVAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG POTENCY;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
NEUROECTODERM TUMOR;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
TUMOR BIOPSY;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BLOTTING, WESTERN;
BRAIN;
BRAIN NEOPLASMS;
CASPASE 3;
CASPASES;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
ISOENZYMES;
LACTONES;
MEMBRANE PROTEINS;
NEUROECTODERMAL TUMORS, PRIMITIVE;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROTEIN-SERINE-THREONINE KINASES;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-AKT;
PYRAZOLES;
SULFONAMIDES;
SULFONES;
TIME FACTORS;
TUMOR CELLS, CULTURED;
|
EID: 0037030577
PISSN: 03043835
EISSN: None
Source Type: Journal
DOI: 10.1016/S0304-3835(02)00003-4 Document Type: Article |
Times cited : (54)
|
References (28)
|